The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes. - Wikidata - wikimedia - TriplyDB

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

http://www.wikidata.org/entity/Q37380507

about

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview.Physicians' attitudes toward post-MI aspirin prophylaxis: findings from an online questionnaire in Europe and Latin America.

P2860

Q35141772-C7687203-63FE-430F-B602-150741BBCA99 Q43235282-93FBF436-F925-4D36-97CE-A768EB4F62EE

P2860

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

http://www.wikidata.org/entity/Q37380507

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The potential role of prasugre ...... with acute coronary syndromes.

@en

The potential role of prasugre ...... with acute coronary syndromes.

@nl

type

label

The potential role of prasugre ...... with acute coronary syndromes.

@en

The potential role of prasugre ...... with acute coronary syndromes.

@nl

prefLabel

The potential role of prasugre ...... with acute coronary syndromes.

@en

The potential role of prasugre ...... with acute coronary syndromes.

@nl

P1433

Q37380507-EE41D4B2-1541-4725-946D-5E4B641ECE0A

P1476

Q37380507-926586FB-22AD-4D6E-BF1F-67213B1F6E0C

P2093

Q37380507-30851849-7495-4FAE-84A4-D9985D17A662

P2860

Q37380507-01157C53-92F5-4650-A56C-A6B04D56AFAC

Q37380507-02C6627A-D222-4A63-93B5-62D1DF082B23

Q37380507-04B1ACD2-2E63-4CCB-B307-6A27DBFE549A

Q37380507-0B1BB229-2E38-4968-BDBE-32AE8CDD53AB

Q37380507-12C6627F-A603-440C-B30A-806F7F865870

Q37380507-2C02433A-A236-45F8-AEB9-2C46CAC6A73B

Q37380507-340B7915-FC97-42E6-97BB-248BD420B5EB

Q37380507-398F02F9-99FF-4410-84FD-A1189B09A76D

Q37380507-43A5E488-D686-462E-BC44-1D0933329EBA

Q37380507-4F13BCD8-1EA4-4B6D-AAB4-CBE596DAD053

P304

Q37380507-B05F29BE-B52C-4F03-9C60-B15B02FB5A60

P31

Q37380507-323717B6-54C5-44B5-A037-1F1F8424E795

P356

Q37380507-08775087-C33D-4AAE-AAC1-BD077F869596

P407

Q37380507-CF0392BD-7850-40A4-93AE-A0400BEB7798

P433

Q37380507-B7EA1A69-47F3-4BE6-8C36-2844D36D2135

P478

Q37380507-13C82C10-2C51-41DF-A0AC-C55ACF1C75E7

P577

Q37380507-95ED6EE9-4619-480F-914B-9A10CA69B39D

P698

Q37380507-D28F0677-64A5-4787-AA2F-DEDEC4ABAD30

P356

PGM.2009.01.1955

P1433

Postgraduate Medicine

P1476

The potential role of prasugre ...... with acute coronary syndromes.

@en

P2093

Peter P Toth

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Get with the guidelines for cardiovascular secondary prevention: pilot results

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

P304

59-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2009.01.1955

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19179814

http://www.w3.org/2001/XMLSchema#string